MedTrace Logo

Safety and Effectiveness of Ciprofol in Cardiac Surgery Anesthesia

NCT05892471 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-06-07

No results posted yet for this study

Summary

Ciprofol, a novel intravenous general anesthetic with a chemical structure akin to propofol, boasts significantly enhanced potency. It offers a rapid onset, reduced incidence of injection pain, and minor impact on the cardiovascular system. However, clinical research regarding ciprofol's use for anesthesia induction in cardiac surgery remains limited. The investigators want to assesse the safety and effectiveness of ciprofol in cardiac surgery anesthesia

Conditions

  • Anesthesia

Interventions

DRUG

ciprofol injection

Patients in ciprofol group 0.3 mg/kg ciprofol for induction of anesthesia

DRUG

Propofol injection

Patients in propofol group received 1.5 mg/kg propofol for induction of anesthesia

Sponsors & Collaborators

  • Le Yu

    lead OTHER

Principal Investigators

  • Handong Sun · Shanghai East Hospital of Tongji University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2023-08-01
Completion
2023-09-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05892471 on ClinicalTrials.gov